Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 18, 2022
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
Tue, May 17, 2022
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
Yigal Nochomovitz Maintained (UBX) at Strong Buy with Decreased Target to $50 on, May 17th, 2022
Yigal Nochomovitz of Citigroup, Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Decreased Target from $60 to $50 on, May 17th, 2022.
Yigal, nor any peers, have made any analyst calls on UBX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30